Xeris Biopharma Inc

Xeris Biopharma (0A8E)

[ADVERT]
Company name:Xeris Biopharma Inc
EPIC:0A8ETrading Currency:USD
Market Sector:SXELISIN:
Market Segment:SSX4Share Type:DE
WWW Address:Description:XERIS BIOPHARMA ORD SHS
Industry Sector:
 Price Price Change [%] Bid Offer Open High Low Volume
 - images.advfn.com/imagesnew/2/gb/dot [] - - - - - 9,010
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 - - - - - - - -

Xeris Biopharma Key Figures

KEY FIGURES at Previous Day's Close - Not Available

Xeris Biopharma Balance Sheet

Sorry No Data Available

Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Xeris Biopharma Historic Returns

Sorry No Data Available

Xeris Biopharma Key Management Ratios

Xeris Biopharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio - 
Tobin's Q Ratio (excl. intangibles)- 
Dividend Yield-%
Market-to-Book Ratio- 
Price-to-Pre-Tax Profit PS- 
Price-to-Retained Profit PS- 
Price-to-Cash Flow PS- 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS- 
Price-to-Cash PS- 
Net Working Capital PS- 
Price Pct to Working Capital PS-%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Xeris Biopharma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-%
Net Gearing (excl. Intangibles)-%
Gross Gearing-%
Gross Gearing (excl. Intangibles)-%
Gearing Under 1 Year-%
Gearing Under 1 Year (excl. Intgbl)-%
Assets/Equity- 
Cash/Equity- 
(Liquidity Ratios)
Net Working Capital to Total Assets-%
Current Ratio- 
Quick Ratio (Acid Test)- 
Liquidity Ratio- 
Cash & Equiv/Current Assets-%
(Solvency Ratios)
Enterprise Value-m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets- 
CFO/Debt- 
Total Debt/Equity Market Value- 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit- 
Total Debt-m
Total Debt/Net Current Assets-%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
Sorry No Data AvailableSorry No Data Available

Xeris Biopharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-%
Return On Assets (ROA)-%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-%
Return On Investment (ROI)-%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Xeris Biopharma Dividends

Sorry No Data Available

Xeris Biopharma Fundamentals

Sorry No Data Available

Xeris Biopharma Balance Sheet

Sorry No Data Available

Xeris Biopharma Cash Flow Statement

Sorry No Data Available

Xeris Biopharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
0A8E
Xeris Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220121 21:58:05